Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $48.9792 (-0.33%) ($48.1940 - $49.1398) on Wed. Feb. 24, 2016. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.39% (three month average) | RSI | 40 | Latest Price | $48.9792(-0.33%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | ABBV advances 0.4% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) XLV(62%) VYM(49%) IVE(47%) SPY(47%) IBB(46%) | Factors Impacting ABBV price | ABBV will decline at least -1.195% in a week (0% probabilities). VIXM(-20%) TLT(-14%) UUP(-10%) IGOV(-3%) GLD(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.195% (StdDev 2.39%) | Hourly BBV | 0 () | Intraday Trend | 0.4% | | | |
|
5 Day Moving Average | $48.91(0.14%) | 10 Day Moving Average | $48.25(1.51%) | 20 Day Moving Average | $48.58(0.82%) | To recent high | -9.3% | To recent low | 7.2% | Market Cap | $86.413b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |